SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+7.31%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$161M
AUM Growth
+$161M
(+0.78%)
Cap. Flow
+$3.37M
Cap. Flow
% of AUM
2.09%
Top 10 Holdings %
Top 10 Hldgs %
51.76%
Holding
60
New
21
Increased
7
Reduced
10
Closed
9
Top Buys
| 1 |
Cigna
CI
|
$6.66M |
| 2 |
Cardinal Health
CAH
|
$6.19M |
| 3 |
Humana
HUM
|
$5.3M |
| 4 |
MEI Pharma
MEIP
|
$4.92M |
| 5 |
HCA Healthcare
HCA
|
$4.61M |
Top Sells
| 1 |
Sanofi
SNY
|
$10.3M |
| 2 |
Viking Therapeutics
VKTX
|
$9.45M |
| 3 |
Biogen
BIIB
|
$8.74M |
| 4 |
Gyre Therapeutics
GYRE
|
$7.92M |
| 5 |
Eli Lilly
LLY
|
$6.37M |
Sector Composition
| 1 | Healthcare | 89.68% |
| 2 | Financials | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kura Oncology
KURA
$686M
| $15.2M | 8.43% | 837,604 +180,193 | +27% | +$3.28M |
|
2
Elevance Health
ELV
$71.8B
| $10.4M | 5.74% | 43,601 -8,786 | -17% | -$2.09M |
|
|
3
HCA Healthcare
HCA
$94.5B
| $9.98M | 5.52% | 97,230 +44,900 | +86% | +$4.61M |
|
|
4
MEI Pharma
MEIP
$160M
| $8.61M | 4.76% | 2,183,986 +1,249,423 | +134% | +$4.92M |
|
5
Icon
ICLR
$13.8B
| $7.33M | 4.05% | 55,332 +19,132 | +53% | +$2.54M |
|
|
AET
6
DELISTED
Aetna Inc
AET
| $7.18M | 3.97% | 39,135 +7,500 | +24% | +$1.38M |
|
|
7
Cigna
CI
$80.3B
| $6.66M | 3.68% | +39,200 | New | +$6.66M |
|
|
8
Cardinal Health
CAH
$35.5B
| $6.19M | 3.42% | +126,770 | New | +$6.19M |
|
|
9
Sanofi
SNY
$121B
| $6M | 3.32% | 150,058 -258,563 | -63% | -$10.3M |
|
10
Boston Scientific
BSX
$156B
| $5.97M | 3.3% | 182,633 -42,830 | -19% | -$1.4M |
|
|
11
Gyre Therapeutics
GYRE
$703M
| $5.5M | 3.04% | 471,448 -678,541 | -59% | -$7.92M |
|
|
12
Humana
HUM
$36.5B
| $5.3M | 2.93% | +17,793 | New | +$5.3M |
|
13
Philips
PHG
$26.2B
| $4.3M | 2.38% | 101,742 +25,000 | +33% | +$1.06M |
|
14
Novartis
NVS
$245B
| $4.16M | 2.3% | +55,000 | New | +$4.16M |
|
15
Rigel Pharmaceuticals
RIGL
$697M
| $3.96M | 2.19% | +1,398,618 | New | +$3.96M |
|
16
Willis Towers Watson
WTW
$31.9B
| $3.94M | 2.18% | +25,969 | New | +$3.94M |
|
17
Universal Health Services
UHS
$11.6B
| $3.94M | 2.18% | +35,323 | New | +$3.94M |
|
18
Revvity
RVTY
$10.5B
| $3.85M | 2.13% | +52,620 | New | +$3.85M |
|
19
electroCore
ECOR
$40.3M
| $3.52M | 1.95% | +213,400 | New | +$3.52M |
|
|
CELG
20
DELISTED
Celgene Corp
CELG
| $3.33M | 1.84% | 41,942 +10,762 | +35% | +$855K |
|
|
SPPI
21
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $3.01M | 1.66% | +143,550 | New | +$3.01M |
|
|
MRTX
22
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.96M | 1.64% | +60,050 | New | +$2.96M |
|
23
Alnylam Pharmaceuticals
ALNY
$58.5B
| $2.94M | 1.62% | +29,835 | New | +$2.94M |
|
24
Incyte
INCY
$16.5B
| $2.81M | 1.56% | +42,000 | New | +$2.81M |
|
|
RVNC
25
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.78M | 1.54% | +101,292 | New | +$2.78M |
|